About Krueppel-like factor 11
Krueppel-like factor 11 (KLF11) is a protein
from Homo sapiens identified by UniProt accession
O14901, 512 residues long.
MolForge cross-references it against 0 known binders and
136 disease associations.
Target properties
| Protein name | Krueppel-like factor 11 |
| UniProt accession | O14901 |
| Gene | KLF11 |
| Organism | Homo sapiens |
| Length | 512 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (136)
Diseases linked to this target (Open Targets).
- MODY · score 0.58
- heel bone mineral density · score 0.43
- body height · score 0.42
- erythrocyte count · score 0.41
- mean corpuscular volume · score 0.39
- forced expiratory volume · score 0.39
- neuroticism measurement · score 0.38
- vital capacity · score 0.36
- appendicular lean mass · score 0.35
- lean body mass · score 0.34
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O14901-F1 | alphafold | PREDICTED | 48.81 | — |
Amino-acid sequence (512 residues)
MHTPDFAGPD DARAVDIMDI CESILERKRH DSERSTCSIL EQTDMEAVEA LVCMSSWGQR SQKGDLLRIR PLTPVSDSGD VTTTVHMDAA TPELPKDFHS LSTLCITPPQ SPDLVEPSTR TPVSPQVTDS KACTATDVLQ SSAVVARALS GGAERGLLGL EPVPSSPCRA KGTSVIRHTG ESPAACFPTI QTPDCRLSDS REGEEQLLGH FETLQDTHLT DSLLSTNLVS CQPCLHKSGG LLLTDKGQQA GWPGAVQTCS PKNYENDLPR KTTPLISVSV PAPPVLCQMI PVTGQSSMLP AFLKPPPQLS VGTVRPILAQ AAPAPQPVFV GPAVPQGAVM LVLPQGALPP PAPCAANVMA AGNTKLLPLA PAPVFITSSQ NCVPQVDFSR RRNYVCSFPG CRKTYFKSSH LKAHLRTHTG EKPFNCSWDG CDKKFARSDE LSRHRRTHTG EKKFVCPVCD RRFMRSDHLT KHARRHMTTK KIPGWQAEVG KLNRIASAES PGSPLVSMPA SA
Explore Krueppel-like factor 11 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets